35 /100
MEDIUM RISK
Score updated Apr 13, 2026

MCRB

Seres Therapeutics, Inc. — Stock Dilution Tracker

Track MCRB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track MCRB — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
65
📊 Float Risk
35
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
💰 Capital Raise 15%
• Under 12 months cash (10mo)
🔔 Track MCRB — Get forecast alerts →
💹 Market Data
Market Cap$79.76M
Shares Outstanding9.59M
Float7.28M
Cash$45.77M
Debt$82.97M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 6.5% shares (2025Q4 vs prior)
39 institutional holders · 2.87M shares
#1 Flagship Pioneering, LLC 1.16M shares
#2 SUSQUEHANNA INTERNATIONAL GROUP, LLP 332.8K shares
#3 VANGUARD GROUP INC 324.2K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest597.3K
Days to Cover12.1
% of Float8.2%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2015
4 INSIDER TRANSACTION Mar 11, 2026
3 FORM3 Mar 11, 2026
4 INSIDER TRANSACTION Mar 06, 2026
Full SEC filing analysis available with free account
📰 Recent News
Seres Therapeutics: Q4 Earnings Snapshot Associated Press Finance · Mar 12
Track MCRB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MCRB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required